LU77666A1 - - Google Patents

Info

Publication number
LU77666A1
LU77666A1 LU77666A LU77666A LU77666A1 LU 77666 A1 LU77666 A1 LU 77666A1 LU 77666 A LU77666 A LU 77666A LU 77666 A LU77666 A LU 77666A LU 77666 A1 LU77666 A1 LU 77666A1
Authority
LU
Luxembourg
Application number
LU77666A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU77666(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of LU77666A1 publication Critical patent/LU77666A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)
LU77666A 1976-07-01 1977-06-30 LU77666A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (1)

Publication Number Publication Date
LU77666A1 true LU77666A1 (xx) 1977-10-07

Family

ID=20328354

Family Applications (2)

Application Number Title Priority Date Filing Date
LU77666A LU77666A1 (xx) 1976-07-01 1977-06-30
LU88310C LU88310I2 (fr) 1976-07-01 1993-06-16 Foscarnet (Foscavir)

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU88310C LU88310I2 (fr) 1976-07-01 1993-06-16 Foscarnet (Foscavir)

Country Status (22)

Country Link
US (4) US4215113A (xx)
JP (1) JPS536428A (xx)
AT (1) AT369014B (xx)
AU (1) AU510809B2 (xx)
BE (1) BE856355A (xx)
BG (1) BG60834B2 (xx)
CA (1) CA1077848A (xx)
CH (1) CH641471A5 (xx)
DE (1) DE2728685C2 (xx)
DK (1) DK288877A (xx)
FI (1) FI772030A (xx)
FR (1) FR2356424A1 (xx)
GB (1) GB1585615A (xx)
HK (1) HK28984A (xx)
IE (1) IE45753B1 (xx)
LU (2) LU77666A1 (xx)
MX (1) MX9203635A (xx)
MY (1) MY8500125A (xx)
NL (2) NL180068C (xx)
NO (1) NO772299L (xx)
SE (1) SE7607496L (xx)
SG (1) SG80383G (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003007A2 (en) * 1977-12-22 1979-07-11 Astra Läkemedel Aktiebolag Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
ATE24836T1 (de) * 1982-02-12 1987-01-15 Ens Bio Logicals Inc Antivirale zusammensetzungen.
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
WO1987002246A1 (en) * 1985-10-21 1987-04-23 William Sergio Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
WO1996039148A1 (en) * 1995-06-06 1996-12-12 University Of Southern California Methods and compositions for inhibiting cytomegalovirus replication
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
JP2006520374A (ja) * 2003-03-14 2006-09-07 エピスタム リミテッド 非ウィルス性上皮損傷の治療および／または予防
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
WO2006119174A1 (en) 2005-04-30 2006-11-09 Ocular Surface Center, P.A. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US9006219B2 (en) 2008-03-12 2015-04-14 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (en) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Transmucosal dosage forms of foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003007A2 (en) * 1977-12-22 1979-07-11 Astra Läkemedel Aktiebolag Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
EP0003275A1 (en) * 1977-12-22 1979-08-08 Astra Läkemedel Aktiebolag Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections
EP0003007A3 (en) * 1977-12-22 1979-08-08 Astra Lakemedel Aktiebolag Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
US4372894A (en) 1977-12-22 1983-02-08 Astra Lakemedel Aktiebolag Phosphonoformic acid esters
US4536400A (en) * 1977-12-22 1985-08-20 Astra Lakemedel Aktiebolag Phosphonoformic acid esters

Also Published As

Publication number Publication date
US4215113A (en) 1980-07-29
JPS536428A (en) 1978-01-20
MY8500125A (en) 1985-12-31
FR2356424A1 (fr) 1978-01-27
FI772030A (xx) 1978-01-02
SG80383G (en) 1984-08-03
BG60834B2 (bg) 1996-04-30
US4771041A (en) 1988-09-13
DK288877A (da) 1978-01-02
SE7607496L (sv) 1978-01-02
BE856355A (fr) 1978-01-02
NL180068B (nl) 1986-08-01
DE2728685A1 (de) 1978-01-12
NL930053I1 (nl) 1993-09-01
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
NL7707235A (nl) 1978-01-03
DE2728685C2 (de) 1982-09-16
AU2650577A (en) 1979-01-04
US4339445A (en) 1982-07-13
FR2356424B1 (xx) 1980-04-18
MX9203635A (es) 1992-09-01
CH641471A5 (de) 1984-02-29
US4665062A (en) 1987-05-12
AT369014B (de) 1982-11-25
ATA465477A (de) 1982-04-15
JPS562046B2 (xx) 1981-01-17
NL930053I2 (nl) 1994-01-03
AU510809B2 (en) 1980-07-17
NO772299L (no) 1978-04-25
NL180068C (nl) 1987-01-02
GB1585615A (en) 1981-03-11
IE45753B1 (en) 1982-11-17
CA1077848A (en) 1980-05-20
LU88310I2 (fr) 1994-05-04

Similar Documents

Publication Publication Date Title
DE2756577C2 (xx)
DE2755136C2 (xx)
DE2760264A1 (xx)
DE2746330C2 (xx)
DE2656160C2 (xx)
DE2760272C2 (xx)
DE2756741C2 (xx)
DK138768C (xx)
CH617305B (xx)
FR2351079B1 (xx)
DE2634582C3 (xx)
DE2729116C2 (xx)
DE2719565C2 (xx)
JPS5358668U (xx)
CS175527B1 (xx)
CS175516B1 (xx)
CH608397A5 (xx)
DD125826A1 (xx)
CH613749A5 (xx)
CH614413A5 (xx)
CH614797A5 (xx)
CH612549A5 (xx)
CH612393A5 (xx)
CH624263GA3 (xx)
CH611187A5 (xx)

Legal Events

Date Code Title Description
DT Application date
TA Annual fee